AtrimusRx
Swedish pharmaceutical company specializing in unlicensed medicine import, distribution, and 3D-printed personalized pharmaceutical compounding
- CEO / Founder
- Nicky Nadem
- Team Size
- 11-50
- Stage
- Growth Stage
- Total Funding
- Bootstrapped
- Latest Round
- Bootstrapped
Technology & Products
Key Products
Atrimus Px (Prescription Precision) — 3D-printed personalized pharmaceutical compounding platform; import and distribution of unlicensed/licensed medicines from US and EES markets; digital shortage management app and database (Restnoteringsapp); online pharmacy; wholesale distribution
Technological Advantage
Validated 3D printing (additive manufacturing) for extemporaneous pharmaceutical compounding in a regulated community pharmacy setting; EU GDP-compliant supply chain; holds both wholesale distribution and community pharmacy licenses; digital platform for shortage management
Differentiation
Value Proposition
Ensuring access to treatment during medicine shortages through import of unlicensed medicines from the US and EES, combined with extemporaneous compounding via additive manufacturing (3D printing) for personalized dosages and formulations
How They Differentiate
Combines traditional pharmaceutical import/distribution with in-house 3D-printed compounding under a single licensed pharmacy operator; holds both wholesale and retail pharmacy licenses; operates a digital shortage management platform; first to implement 3D-printed medicines in Swedish community pharmacy practice
Market & Competition
Target Customers
Hospitals, pharmacies (community and hospital), healthcare professionals, and patients requiring unlicensed or personalized medicines
Industry Verticals
Pharmaceuticals, Healthcare, Pediatric medicine, Veterinary medicine
Competitors
CurifyLabs (Finland); Sensidose (Sweden); FabRx (UK)
Growth & Milestones
Growth Metrics
Revenue approximately €10-50M (based on Founders Alliance Medium Size Companies category criteria for 2024 fiscal year); profitable per Founders Alliance jury motivation
Major Milestones
2016: Founded by Nicky Nadem; 2023: Nicky Nadem awarded "Årets pionjär" (Pioneer of the Year) by IFS, prize from King Carl XVI Gustaf; 2025: Nicky Nadem wins Gold - Founder of the Year (Medium Size Companies) by Founders Alliance; 2025: Obtained retail and online pharmacy license; 2026: First in Sweden to implement validated 3D-printed pharmaceutical compounding in community pharmacy practice; 2026: Partner in EU4Health-funded RoboPharma project (€5.6M)
Notable Customers
Swedish hospitals and pharmacies; Greek healthcare market (via Business Sweden-supported re-entry)